Officer Michael Kaseta Files Intent to Sell Over $5 Million in Liquidia Stock
LQDA has more than doubled off its 52-week low of $11.26.
Summary
An officer at Liquidia Corp has filed a Form 144 to sell approximately $5.1 million in common stock, a notable transaction amidst the company's ongoing legal challenges.
Key Events · Ownership and Investor Activity · LQDA
-
Officer Files Intent to Sell Shares
Michael Kaseta, an officer, filed a Form 144 to sell 133,789 shares of common stock, valued at approximately $5.1 million.
-
Significant Insider Distribution
This proposed sale represents about 0.14% of the company's market capitalization and contributes to a pattern of over $6 million in net insider sales over the past 90 days.
-
Context of Legal Challenges
The intent to sell occurs as Liquidia Corp faces critical patent and trade secret litigations that could impact its market access.
Analysis · LQDA · Life Sciences
Michael Kaseta, an officer at Liquidia Corp, has filed a Form 144 indicating an intent to sell approximately $5.1 million worth of common stock. This significant proposed sale, representing about 0.14% of the company's market capitalization, comes amidst ongoing critical patent and trade secret litigations that pose a threat to the company's market access. While the filing notes the shares were acquired through the exercise of stock options, the intent to sell such a substantial amount by an officer could be interpreted negatively by investors, especially given the company's legal challenges. This follows a pattern of insider distribution, with over $6 million in net sales by insiders in the last 90 days.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LQDA was trading at $40.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $11.26 to $46.67. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.